吉斯美（武汉）制药有限公司
Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
29
NMPA:29
Drug Approvals
Bortezomib for Injection
- Product Name
- 注射用硼替佐米
- Approval Number
- 国药准字H20253276
- Approval Date
- Jan 24, 2025
NMPA
Fluorouracil for Injection
- Product Name
- 注射用氟尿嘧啶
- Approval Number
- 国药准字H20050465
- Approval Date
- Jul 27, 2022
NMPA
Dacarbazine for Injection
- Product Name
- 注射用达卡巴嗪
- Approval Number
- 国药准字H20057360
- Approval Date
- Jul 27, 2022
NMPA
Fluorouracil for Injection
- Product Name
- 注射用氟尿嘧啶
- Approval Number
- 国药准字H20050466
- Approval Date
- Jul 27, 2022
NMPA
Methotrexate for Injection
- Product Name
- 注射用甲氨蝶呤
- Approval Number
- 国药准字H20045041
- Approval Date
- Jul 20, 2022
NMPA
Nimostine Hydrochloride for Injection
- Product Name
- 注射用盐酸尼莫司汀
- Approval Number
- 国药准字H20058694
- Approval Date
- Mar 3, 2022
NMPA
- Prev
- 1
- 2
- 3
- Next
Clinical Trials
No trials found
News
No news found